Aardvark Therapeutics: Regulatory Uncertainty Clouds ARD-101 Path Forward
Aardvark Therapeutics Inc AARD
$4.11
▼ -2.14%
($-0.09)
Open
$4.17
Prev Close
$4.20
Day Range
$3.90 – $4.19
52W Range
$3.35 – $17.94
Market Cap
$91.63M
Beta
4.38
EPS (TTM)
$-3.21
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2025-02-13 |
| Shares Out. | 21,820,000 |
| Website | aardvarktherapeutics.com/ ↗ |
| Phone | 18582257696 |
Aardvark Therapeutics Inc is a publicly traded company under the ticker symbol AARD on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-05-01)
📰 Latest News for AARD
Here are the top movers in Friday's session.
Let's uncover which stocks are experiencing notable gaps during today's session.
12 Health Care Stocks Moving In Friday's Intraday Session
B. Riley Securities Maintains Buy on Aardvark Therapeutics, Lowers Price Target to $7
These stocks are moving in today's pre-market session
This Unity Bancorp Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Aardvark Therapeutics Shares Plunge After FDA Hold on ARD-101 New Drug Application